MK-251
MK-251 is an orally active anti-arrhythmic agent. MK-251 prevents or modifies ventricular arrhythmias induced in dogs and baboons by tetrafluorethylbutylamine. MK-251 antagonizes the arrhythmias caused by Digoxin (HY-B1049) in cats. MK-251 at effective doses has little effect on basic cardiovascular parameters such as blood pressure, cardiac output, myocardial contractility and ventricular conduction, thus demonstrating its unique advantages[1].
Product Specifications
CAS Number
[36386-71-7]
UNSPSC
12352005
Target
Others
Related Pathways
Others
Field of Research
Cardiovascular Disease
Smiles
FC(C1=CC=CC=C1)(C(F)(C2=CC=C(C(C)(C)N)C=C2)F)F
Molecular Formula
C17H17F4N
Molecular Weight
311.32
References & Citations
[1]Torchiana ML, et al. The antiarrhythmic and hemodynamic actions of alpha, alpha-dimethyl-4- (alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine (MK-251) . J Pharmacol Exp Ther. 1975 Aug;194 (2) :415-26.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6204519-01 0.1 mL
PLGF (PGFL, PIGF, placental growth factor (PGF), PlGF2, Vascular endothelial growth factor related protein) (BSA & Azide Free) (MaxLight 490)
Ask
View Details MBS6204519-02 5x 0.1 mL
PLGF (PGFL, PIGF, placental growth factor (PGF), PlGF2, Vascular endothelial growth factor related protein) (BSA & Azide Free) (MaxLight 490)
Ask
View Details 132766-APC 100 µL
RPL10 (60S Ribosomal Protein L10, Laminin Receptor Homolog, Protein QM, Tumor Suppressor QM, DXS648E, QM) (APC)
Ask
View Details 